chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Maternal exposure during breast feeding
Clinical narrative: Breastfeeding; Dizziness and lightheaded; This spontaneous case was reported by a health care professional and describes the occurrence of DIZZINESS (Dizziness and lightheaded) and MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced DIZZINESS (Dizziness and lightheaded). On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding). At the time of the report, DIZZINESS (Dizziness and lightheaded) and MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Pain in extremity, Pruritus
Clinical narrative: Itchiness; Sore arm; Redness; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Redness) and INJECTION SITE ERYTHEMA (injection site redness) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchiness), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Redness) and INJECTION SITE ERYTHEMA (injection site redness). At the time of the report, PRURITUS (Itchiness) and INJECTION SITE ERYTHEMA (injection site redness) had resolved and PAIN IN EXTREMITY (Sore arm) and ERYTHEMA (Redness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.   Treatment information was not provided.  Patient did not experienced any adverse events after taking second dose of vaccine.    Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14 Jul 2021 contains outcome of the events as recovered.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (slightly sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced VACCINATION SITE PAIN (slightly sore arm). At the time of the report, VACCINATION SITE PAIN (slightly sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Nasal congestion, Nasopharyngitis, Pulmonary pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Congestion), CHEST PAIN (soreness in chest), PULMONARY PAIN (soreness in lungs) and COUGH (coughing) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included DEXLANSOPRAZOLE (DEXILANT) for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Congestion), CHEST PAIN (soreness in chest), PULMONARY PAIN (soreness in lungs) and COUGH (coughing). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Congestion), CHEST PAIN (soreness in chest), PULMONARY PAIN (soreness in lungs) and COUGH (coughing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Nausea; Muscle ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of   in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-014103 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Myalgia, Nausea
Clinical narrative: headache; severe cramps; muscle aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MUSCLE SPASMS (severe cramps), MYALGIA (muscle aches) and NAUSEA (nausea) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (headache), MUSCLE SPASMS (severe cramps), MYALGIA (muscle aches) and NAUSEA (nausea). At the time of the report, HEADACHE (headache), MUSCLE SPASMS (severe cramps), MYALGIA (muscle aches) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Vaccination site is itchy; Vaccination site is swollen; Vaccination site is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Vaccination site is itchy), VACCINATION SITE SWELLING (Vaccination site is swollen) and VACCINATION SITE ERYTHEMA (Vaccination site is red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included Colitis collagenous, Addison's disease and AFib. Concurrent medical conditions included Sulfonamide allergy. Concomitant products included DABIGATRAN ETEXILATE MESILATE (PRADAXA) and METOPROLOL for AFib, PREDNISONE for Addison's disease.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination site is swollen) and VACCINATION SITE ERYTHEMA (Vaccination site is red). On 19-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Vaccination site is itchy). At the time of the report, VACCINATION SITE PRURITUS (Vaccination site is itchy) outcome was unknown and VACCINATION SITE SWELLING (Vaccination site is swollen) and VACCINATION SITE ERYTHEMA (Vaccination site is red) had resolved.            No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Patient demographics updated. Medical history were added. Suspected product date changed and dose added. Concomitant products indication were updated. Events outcome were updated.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Influenza like illness, Nausea
Clinical narrative: dizziness; headache; flu-like symptoms; fever; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided.).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizziness), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: dizziness; headache; flu-like symptoms; fever; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided.).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizziness), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: Hot to touch injection site; Rash at the injection site; Red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch injection site), VACCINATION SITE RASH (Rash at the injection site) and INJECTION SITE ERYTHEMA (Red at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011520A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch injection site), VACCINATION SITE RASH (Rash at the injection site) and INJECTION SITE ERYTHEMA (Red at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot to touch injection site), VACCINATION SITE RASH (Rash at the injection site) and INJECTION SITE ERYTHEMA (Red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Body aches; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HEADACHE (Headache) and FATIGUE (Fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Body aches), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (Body aches), HEADACHE (Headache) and FATIGUE (Fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was provided.   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination complication
Clinical narrative: Feels very tired; Felt very sick; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt very sick) and FATIGUE (Feels very tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery (She had 3 bypasses from 10 years ago.). Concurrent medical conditions included Hyperlipidemia and Type 2 diabetes mellitus.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION COMPLICATION (Felt very sick). On an unknown date, the patient experienced FATIGUE (Feels very tired). At the time of the report, VACCINATION COMPLICATION (Felt very sick) outcome was unknown and FATIGUE (Feels very tired) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Hot at injection site; Big red patch on left arm at the injection site that was 2 inches wide and 3 inches long; Itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Big red patch on left arm at the injection site that was 2 inches wide and 3 inches long) and VACCINATION SITE PRURITUS (Itchiness at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Big red patch on left arm at the injection site that was 2 inches wide and 3 inches long) and VACCINATION SITE PRURITUS (Itchiness at injection site). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Big red patch on left arm at the injection site that was 2 inches wide and 3 inches long) and VACCINATION SITE PRURITUS (Itchiness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up received on 20 Apr 2021. Now new information was reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia, White blood cell count, White blood cell count decreased
Clinical narrative: white blood cell count decreased; temperature of 102.4°F; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature of 102.4°F), HEADACHE (headache) and WHITE BLOOD CELL COUNT DECREASED (white blood cell count decreased) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (temperature of 102.4°F) and HEADACHE (headache). On 11-Feb-2021, the patient experienced WHITE BLOOD CELL COUNT DECREASED (white blood cell count decreased). On 11-Feb-2021, HEADACHE (headache) had resolved. At the time of the report, PYREXIA (temperature of 102.4°F) and WHITE BLOOD CELL COUNT DECREASED (white blood cell count decreased) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, White blood cell count: 5.000 (Low) decreased. On an unknown date, Body temperature: 102.4 °F.         This case was linked to MOD-2021-048139 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site pain
Clinical narrative: Red rash on stomach and has spread to his sides; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash on stomach and has spread to his sides) and VACCINATION SITE PAIN (Sore arm) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Red rash on stomach and has spread to his sides) and VACCINATION SITE PAIN (Sore arm). At the time of the report, RASH ERYTHEMATOUS (Red rash on stomach and has spread to his sides) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Vaccination complication
Clinical narrative: Felt very sick; Very weak; Coughs all the time; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt very sick), ASTHENIA (Very weak) and COUGH (Coughs all the time) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Cholesterol and Blood pressure high.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt very sick), ASTHENIA (Very weak) and COUGH (Coughs all the time). At the time of the report, VACCINATION COMPLICATION (Felt very sick), ASTHENIA (Very weak) and COUGH (Coughs all the time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Paint at injections site on left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Paint at injections site on left arm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     The patient's past medical history included Asthma. Concomitant products included LISINOPRIL, MULTIVITAMIN & MINERAL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Paint at injections site on left arm). On 10-Jan-2021, VACCINATION SITE PAIN (Paint at injections site on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also includes Thyroid medicine, Allergy medicine and Albuterol inhaler.   This case was linked to MOD-2021-015729 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Peripheral swelling
Clinical narrative: Right hand through wrist swollen; severe muscle pain, shoulder pain, getting around is hard; Severe joint pain, shoulder pain,getting around is hard; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Right hand through wrist swollen), MYALGIA (severe muscle pain, shoulder pain, getting around is hard) and ARTHRALGIA (Severe joint pain, shoulder pain,getting around is hard) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and METOPROLOL for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PERIPHERAL SWELLING (Right hand through wrist swollen) and MYALGIA (severe muscle pain, shoulder pain, getting around is hard). 19-Feb-2021, the patient experienced ARTHRALGIA (Severe joint pain, shoulder pain,getting around is hard). At the time of the report, PERIPHERAL SWELLING (Right hand through wrist swollen), MYALGIA (severe muscle pain, shoulder pain, getting around is hard) and ARTHRALGIA (Severe joint pain, shoulder pain,getting around is hard) outcome was unknown.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Pain in extremity, Pruritus, Rash
Clinical narrative: coughing; sneezing; a rash left side of the abdomen/a rash around her neck; a headache since then; a sore arm; general itching all over her body/ still has itching all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm), PRURITUS (general itching all over her body/ still has itching all over), COUGH (coughing), SNEEZING (sneezing) and RASH (a rash left side of the abdomen/a rash around her neck) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (a sore arm) and PRURITUS (general itching all over her body/ still has itching all over). On 17-Feb-2021, the patient experienced COUGH (coughing), SNEEZING (sneezing), RASH (a rash left side of the abdomen/a rash around her neck) and HEADACHE (a headache since then). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 17-Feb-2021, COUGH (coughing) and SNEEZING (sneezing) had resolved. At the time of the report, PAIN IN EXTREMITY (a sore arm), RASH (a rash left side of the abdomen/a rash around her neck) and HEADACHE (a headache since then) outcome was unknown and PRURITUS (general itching all over her body/ still has itching all over) had not resolved.            Concomitant product use was not provided by the reporter.   Reportedly, the patient was advised by healthcare provider to take Benadryl, which helped with symptoms, but had to stop taking very regularly due to side effects of very drowsy.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: event outcome updated, email address and reporter address updated.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: coughing; sneezing; a rash left side of the abdomen/a rash around her neck; a headache since then; a sore arm; general itching all over her body/ still has itching all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm), PRURITUS (general itching all over her body/ still has itching all over), COUGH (coughing), SNEEZING (sneezing) and RASH (a rash left side of the abdomen/a rash around her neck) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (a sore arm) and PRURITUS (general itching all over her body/ still has itching all over). On 17-Feb-2021, the patient experienced COUGH (coughing), SNEEZING (sneezing), RASH (a rash left side of the abdomen/a rash around her neck) and HEADACHE (a headache since then). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 17-Feb-2021, COUGH (coughing) and SNEEZING (sneezing) had resolved. At the time of the report, PAIN IN EXTREMITY (a sore arm), RASH (a rash left side of the abdomen/a rash around her neck) and HEADACHE (a headache since then) outcome was unknown and PRURITUS (general itching all over her body/ still has itching all over) had not resolved.            Concomitant product use was not provided by the reporter.   Reportedly, the patient was advised by healthcare provider to take Benadryl, which helped with symptoms, but had to stop taking very regularly due to side effects of very drowsy.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: event outcome updated, email address and reporter address updated.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall
Clinical narrative: Fallen twice; Severe dizziness; A spontaneous report was received from a consumer concerning a 79-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events severe dizziness, fallen twice/ fall.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 18 Feb 2021, prior to the onset of the events the patient received their dose of mRNA-1273 (lot/batch: 031L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 18 Feb 2021, the patient experienced the event severe dizziness. On an unknown date, the patient experienced the event fallen twice.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events severe dizziness, fallen twice was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: Welting at the injection site; Itching at the injection site; A spontaneous report was received from a consumer concerning herself, who is a 82-years-aged female patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itching at the injection site, welting at the injection site  The patient's medical history was not provided. No concomitant medications were reported.  On 09 Feb 2021, prior to the onset of the events, the patient received their unspecified doses of mRNA-1273 (Lot number: 011620A) via unknown route for prophylaxis of COVID-19 infection.   On an unknown date, patient experienced the event itching about a week later after receiving vaccination. Patient reported that on 18 Feb 2021 she noticed welting at the injection site (all symptoms are ongoing).  Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the event Itching at the injection site, welting at the injection site was not resolved at the time of reporting
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dehydration, Fatigue, Nausea
Clinical narrative: Chills; Feels tired; Sick to stomach; Joints are aching; Dehydrated; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Feels tired), NAUSEA (Sick to stomach), ARTHRALGIA (Joints are aching) and DEHYDRATION (Dehydrated) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced CHILLS (Chills), FATIGUE (Feels tired), NAUSEA (Sick to stomach), ARTHRALGIA (Joints are aching), DEHYDRATION (Dehydrated) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), FATIGUE (Feels tired), NAUSEA (Sick to stomach), ARTHRALGIA (Joints are aching), DEHYDRATION (Dehydrated) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; Feels tired; Sick to stomach; Joints are aching; Dehydrated; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Feels tired), NAUSEA (Sick to stomach), ARTHRALGIA (Joints are aching) and DEHYDRATION (Dehydrated) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced CHILLS (Chills), FATIGUE (Feels tired), NAUSEA (Sick to stomach), ARTHRALGIA (Joints are aching), DEHYDRATION (Dehydrated) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), FATIGUE (Feels tired), NAUSEA (Sick to stomach), ARTHRALGIA (Joints are aching), DEHYDRATION (Dehydrated) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Therapeutic response unexpected, Vaccination site pain
Clinical narrative: Flu-like symptoms; Unexpected benefits (extreme sinus swelling and fatigue suddenly gone); sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), THERAPEUTIC RESPONSE UNEXPECTED (Unexpected benefits (extreme sinus swelling and fatigue suddenly gone)) and VACCINATION SITE PAIN (sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Medical history was not provided.  The patient's past medical history included COVID-19 (Tested negative) on 28-Feb-2020, COVID-19 (Tested negative) on 05-Nov-2020, Sinus disorder NOS (Very swollen sinuses after 1st Covid infection.) on 28-Feb-2020 and Fatigue on 28-Feb-2020. Concurrent medical conditions included Gluten intolerance and Food allergy (Beef, Pork, Oranges, Green beans). Concomitant products included MULTIVITAMIN [VITAMINS NOS], VITAMIN D3, GLUCOSAMINE, LYSINE and PROBIOTICS NOS for an unknown indication.    On 11-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), THERAPEUTIC RESPONSE UNEXPECTED (Unexpected benefits (extreme sinus swelling and fatigue suddenly gone)) and VACCINATION SITE PAIN (sore arm). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), THERAPEUTIC RESPONSE UNEXPECTED (Unexpected benefits (extreme sinus swelling and fatigue suddenly gone)) and VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated 72 hours after the vaccine, the patient woke up and noticed her extreme sinus swelling (requiring chronic use of antibiotics 3 times since first COVID-19 infection in Feb/2020) was suddenly gone. The patient also noted that she had no more fatigue spells and still no sinus problems.   Most recent FOLLOW-UP information incorporated above includes: On 14-Feb-2021: No specific follow-up information recorded. On 24-Apr-2021: No specific follow-up information recorded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site bruising, Vaccination site rash, Vaccination site swelling
Clinical narrative: Rash at injection site; Arm black/blue; Swelling from shoulder to elbow at the injection site; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE BRUISING (Arm black/blue), VACCINATION SITE SWELLING (Swelling from shoulder to elbow at the injection site) and VACCINATION SITE RASH (Rash at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Anemia.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 10-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Arm black/blue) and VACCINATION SITE SWELLING (Swelling from shoulder to elbow at the injection site). On 11-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On 10-Feb-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. At the time of the report, VACCINATION SITE BRUISING (Arm black/blue), VACCINATION SITE SWELLING (Swelling from shoulder to elbow at the injection site) and VACCINATION SITE RASH (Rash at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia, Vomiting
Clinical narrative: Body ache; Vomiting; Fever; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease and Osteoarthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site pain
Clinical narrative: I had some itching, too; My arm at the injection site is still tender; Hurts when you touch it; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K201A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it). At the time of the report, PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Chills; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypoaesthesia, Pain, Pyrexia, Vomiting
Clinical narrative: Body aches; My left hand was going numb, my legs were going numb on and off; Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total; Chills; Fever below 104 F; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN (Body aches), HYPOAESTHESIA (My left hand was going numb, my legs were going numb on and off), VOMITING (Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total), CHILLS (Chills) and PYREXIA (Fever below 104 F) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was given by the reporter.  Concomitant products included METOPROLOL for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 02-Feb-2021, the patient experienced PAIN (Body aches), HYPOAESTHESIA (My left hand was going numb, my legs were going numb on and off), VOMITING (Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total), CHILLS (Chills) and PYREXIA (Fever below 104 F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 03-Feb-2021, VOMITING (Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total) had resolved. On 04-Feb-2021, PYREXIA (Fever below 104 F) had resolved. On 05-Feb-2021, PAIN (Body aches) had resolved. On 06-Feb-2021, HYPOAESTHESIA (My left hand was going numb, my legs were going numb on and off) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Pyrexia: 104 f (Inconclusive) Inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-056957 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: The follow up received on 26-APR-2021. No New Information is added(NNI).
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 101; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 101) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PYREXIA (Fever 101). At the time of the report, PYREXIA (Fever 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Pyrexia: 101 Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Pruritus, Rash
Clinical narrative: missed second dose; a rash starting from his back that spread to his whole body; it is still itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (it is still itching), PRODUCT DOSE OMISSION ISSUE (missed second dose) and RASH (a rash starting from his back that spread to his whole body) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S) from 11-Jan-2021 to an unknown date for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PRURITUS (it is still itching) and RASH (a rash starting from his back that spread to his whole body). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed second dose). The patient was treated with TRIAMCINOLONE for Itch, at a dose of 1 dosage form. At the time of the report, PRURITUS (it is still itching), PRODUCT DOSE OMISSION ISSUE (missed second dose) and RASH (a rash starting from his back that spread to his whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details also included Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Significant follow-up received on 23-Jun-2021 where events has been updated as Remanence of rash and Missed second dose
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Lip swelling, Swelling face, Throat tightness, Urticaria
Clinical narrative: tightness in the throat; facial swelling; hives/very small hives on the trunk; lip swelled; lost her voice; A spontaneous report was received from a consumer (patient's daughter), concerning a 73-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and  experienced tightness in the throat, facial swelling (swelling face), hives/very small hives on the trunk (urticaria), lip swelled (lip swelling), and lost her voice (aphonia).  The patient's medical history was not provided.  Concomitant product use was not provided.  On 04 Feb 2021, about 40 hours prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (batch number: 041L20A ) intramuscularly for the prophylaxis of COVID-19 infection.  On 7 Feb 2021, 40 hours later, the patient experienced hives, facial swelling, and tightness in the throat. The reaction started with very small hives on trunk, face and lip swelled, and she lost her voice.  The daughter reported that events worsened at night.  The reporter's sister took the patient to the emergency room, where she was treated with saline, steroids and diphenhydramine. The patient was still taking the diphenhydramine and steroids.  The daughter said they were going to have more specific allergy tests done on the patient.  Action taken with mRNA-1273 in response to the event was unknown.  It was noted that the patient was reluctant to have the second dose.   The outcome of the events of tightness in the throat, facial swelling, hives/very small hives on the trunk, lip swelled, and lost her voice was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain in extremity, Pruritus, Rash, Skin discolouration
Clinical narrative: Hot; Itchy; It went from bright red to pink; Sore; A pink rash, t grew and grew, about day 6-7-8-9 it was a; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot), PRURITUS (Itchy), SKIN DISCOLOURATION (It went from bright red to pink), RASH (A pink rash, t grew and grew, about day 6-7-8-9 it was a) and PAIN IN EXTREMITY (Sore) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and LISINOPRIL for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced RASH (A pink rash, t grew and grew, about day 6-7-8-9 it was a). On 10-Feb-2021, the patient experienced FEELING HOT (Hot), PRURITUS (Itchy), SKIN DISCOLOURATION (It went from bright red to pink) and PAIN IN EXTREMITY (Sore). At the time of the report, FEELING HOT (Hot), PRURITUS (Itchy), SKIN DISCOLOURATION (It went from bright red to pink) and PAIN IN EXTREMITY (Sore) outcome was unknown and RASH (A pink rash, t grew and grew, about day 6-7-8-9 it was a) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.